|
Intercept
|
1
|
86.76
|
47.38
|
40.30
|
|
Sex
|
2
|
86.60
|
48.11
|
40.35
|
|
Proband breast cancer or ovarian cancer
|
2
|
87.75
|
48.37
|
41.22
|
|
Proband breast cancer
|
2
|
87.65
|
48.16
|
41.30
|
|
Proband bilateral breast cancer
|
2
|
87.62
|
48.32
|
41.06
|
|
Proband ovarian cancer
|
2
|
85.49
|
46.84
|
40.57
|
|
Family affected
|
2
|
86.19
|
45.05
|
41.29
|
|
Number of first-degree and second-degree relativesa
|
2
|
87.45
|
47.93
|
41.26
|
|
Total number of family members affecteda
|
2
|
85.13
|
47.99
|
38.40
|
|
Proportion of family members affecteda
|
2
|
86.99
|
48.30
|
40.32
|
|
Total number of tumors (including bilateral)
|
2
|
83.58
|
47.93
|
36.24
|
|
Total number of breast tumors
|
2
|
87.46
|
47.82
|
38.90
|
|
Number of persons with bilateral cancer
|
2
|
87.23
|
48.17
|
38.61
|
|
Total number of ovarian tumors (tnot)
|
2
|
74.76
|
38.08
|
38.04
|
|
Number of persons with ovarian and/or breast tumors (nbot)
|
2
|
83.17
|
46.35
|
38.29
|
|
BRCAPRO score
|
2
|
67.36
|
35.90
|
33.74
|
|
Myriad score
|
2
|
69.17
|
36.84
|
34.25
|
|
Age at diagnosis (diag)
|
2
|
82.38
|
42.44
|
40.72
|
|
BRCAPRO + Myriad
|
3
|
66.30
|
35.55
|
33.30
|
|
BRCAPRO + Myriad + tnot
|
4
|
64.58
|
34.32
|
-
|
|
BRCAPRO + Myriad + tnot + diag
|
5
|
62.46
|
29.10
|
-
|
|
BRCAPRO + Myriad + tnot + diag + BRCAPRO:diag
|
6
|
-
|
28.29
|
-
|
|
BRCAPRO + tnot + diag + BRCAPRO:diag
|
5
|
-
|
27.51
|
-
|
|
BRCAPRO + Myriad + nbot
|
4
|
-
|
-
|
33.16
|
